Targeting Growth Opportunities
NEW YORK, NY / ACCESSWIRE / April 7, 2015 / HempAmericana, Inc. (HMPQ), a researcher, developer and marketer of industrial hemp products, is pleased to announce it has signed a strategic partnership agreement with Isaac Katan. The agreement is effective immediately and covers a term of three years. Isaac Katan is a self-employed billionaire entrepreneur and real estate developer.
HempAmericana and Isaac Katan agree to identify and collaborate on mutually beneficial opportunities in medical marijuana. Mr. Katan will introduce HempAmericana to his existing relationships, including top Israeli corporations and universities such as Tikun Olam and Ben Gurion University.
HempAmericana Chief Executive Officer, Salvador Rosillo, stated, “We are extremely excited to be working with Isaac Katan and exploring how our hemp-based innovation and products could fit with his relationships and projects. This will further advance our research and development efforts and target growth opportunities. Introduction of new hemp-based products and opportunities will spur revenue growth, as we look to build shareholder value.”
Tikun Olam Ltd. is the first, largest and foremost supplier of medical cannabis in Israel and is one of leading medical cannabis companies in the world. The company is the flag bearer and pioneer of the treatment of patients with medical cannabis in Israel. Tikun Olam is privately held and has been operating under license from the Israel Ministry of Health since 2007. Its founding vision continues to drive it to work hard to provide patients with unparalleled treatment alternatives through the development of industry-leading professional standards for growing and treating patients with the highest quality medical grade cannabis available. Tikun Olam consistently sets the benchmark for the medical cannabis industry in Israel and throughout the globe.
Ben Gurion University was established in 1969 as the University of the Negev with the aim of promoting the development of the Negev desert that comprises more than sixty percent of Israel. The University was later renamed after Israel’s founder and first prime minister David Ben-Gurion, who believed that the future of the country lay in this region. After Ben-Gurion’s death in 1973, the University was renamed Ben-Gurion University of the Negev. Today, Ben-Gurion University is a center for teaching and research with about 20,000 students, and has a major effort in the medical cannabis research and development area.
About HempAmericana, Inc.
HempAmericana, Inc. is an early stage company in the research, development and marketing of industrial hemp products. In essence anything that can be made with plastic can be made with industrial hemp and HempAmericana plans to fill the growing need and demand for hemp based products within the United States.
For more information on HempAmericana, please visit: http://www.hempamericana.com.
Cautionary Language Concerning Forward-Looking Statements
This release contains “forward-looking statements” that include information relating to future events and future financial and operating performance. The words “may,” “would,” “will,” “expect,” “estimate,” “can,” “believe,” “potential” and similar expressions and variations thereof are intended to identify forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management’s good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause these differences include, but are not limited to: fluctuations in demand for HempAmericana products, the introduction of new products, the Company’s ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company’s liquidity and financial strength to support its growth, and other information that may be detailed from time-to-time in HempAmericana filings with the United States Securities and Exchange Commission. Examples of such forward-looking statements in this release include statements regarding future sales, costs and market acceptance of products as well as regulatory actions at the State or Federal level. For a more detailed description of the risk factors and uncertainties affecting HempAmericana please refer to the Company’s Securities and Exchange Commission filings, which are available at www.sec.gov. HempAmericana undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.